Trial Profile
A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Nov 2018
Price :
$35
*
At a glance
- Drugs Ocriplasmin (Primary)
- Indications Retinal disorders
- Focus Registrational; Therapeutic Use
- Sponsors Alcon
- 17 Feb 2015 New trial record